Literature DB >> 18679553

Response to AMA's Council on Ethical and Judicial Affairs draft report on "Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine".

Thomas P Stossel1.   

Abstract

Mesh：

Year:  2008        PMID： 18679553      PMCID： PMC2491684     

Source DB:  PubMed          Journal:  Medscape J Med        ISSN： 1934-1997


× No keyword cloud information.
  15 in total

1.  Physicians and the pharmaceutical industry: is a gift ever just a gift?

Authors:  A Wazana
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

Review 2.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

3.  Extra scrutiny for industry funded trials.

Authors:  Kenneth J Rothman; Stephen Evans
Journal:  BMJ       Date:  2005-12-10

4.  A proposal for radical changes in the drug-approval process.

Authors:  Alastair J J Wood
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

5.  The value of medical spending in the United States, 1960-2000.

Authors:  David M Cutler; Allison B Rosen; Sandeep Vijan
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

Review 6.  The developing physician--becoming a professional.

Authors:  David T Stern; Maxine Papadakis
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

7.  Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.

Authors:  Troyen A Brennan; David J Rothman; Linda Blank; David Blumenthal; Susan C Chimonas; Jordan J Cohen; Janlori Goldman; Jerome P Kassirer; Harry Kimball; James Naughton; Neil Smelser
Journal:  JAMA       Date:  2006-01-25       Impact factor: 56.272

8.  Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006.

Authors:  Keith A A Fox; Philippe Gabriel Steg; Kim A Eagle; Shaun G Goodman; Frederick A Anderson; Christopher B Granger; Marcus D Flather; Andrzej Budaj; Ann Quill; Joel M Gore
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

9.  Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care.

Authors:  Monika M Safford; Richard Shewchuk; Haiyan Qu; Jessica H Williams; Carlos A Estrada; Fernando Ovalle; Jeroan J Allison
Journal:  J Gen Intern Med       Date:  2007-10-24       Impact factor: 5.128

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245
View more
  2 in total

1.  A reply to Thomas Stossel on the AMA-CEJA draft report.

Authors:  Howard Brody
Journal:  Medscape J Med       Date:  2008-07-01

2.  When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis.

Authors:  Norman J Kachuck
Journal:  Neuropsychiatr Dis Treat       Date:  2011-04-19       Impact factor: 2.570
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.